Form 4: Opaleye Management Boosts Sol-Gel Technologies Stake

Opaleye Management Inc., a 10% owner and director, reported multiple purchases of Sol-Gel Technologies Ltd. ordinary shares in late December 2025.

Summary

• Opaleye Management Inc. acquired a total of 2,905 ordinary shares of Sol-Gel Technologies Ltd. through three separate transactions.
• The purchases occurred on December 22, 23, and 26, 2025.
• The shares were acquired at weighted average prices ranging from $41.1537 to $41.6756 per share.
• Following these transactions, Opaleye Management Inc. beneficially owns 377,435 shares indirectly through Opaleye, L.P., and an additional 10,000 shares indirectly through a separately managed account, totaling 387,435 shares.
• Opaleye Management Inc. disclaims beneficial ownership of the reported shares except to the extent of its pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to significant insider buying by a 10% owner and director, indicating confidence in the company's future. However, the filing itself is purely transactional and lacks broader financial or operational details to warrant a higher score.

Positives

• A significant shareholder and director, Opaleye Management Inc., increased its stake in Sol-Gel Technologies Ltd., indicating confidence in the company's future prospects.
• The purchases were made at prices above $41 per share, suggesting a belief in the current valuation or potential for appreciation.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Management Comments

• Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein.
• The filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.

Industry Context

This insider buying activity by a significant shareholder and director suggests a positive internal view of Sol-Gel Technologies Ltd.'s prospects, potentially signaling undervaluation or anticipated positive developments within the pharmaceutical or dermatology industry where Sol-Gel operates.

Comparison to Industry Standards

• This filing reports insider trading activity, which is not directly comparable to industry-wide financial performance benchmarks or specific project results.
• However, insider buying, especially by a 10% owner and director, is generally viewed as a positive signal, aligning with similar observations in other biotech or specialty pharma companies where management or large shareholders increase their stake, such as recent purchases by directors at smaller cap biotechs like ACADIA Pharmaceuticals or DermTech, Inc., which often precede periods of positive news or operational improvements.

Related Party Transactions

• Opaleye Management Inc., a 10% owner and director of Sol-Gel Technologies Ltd., purchased 2,905 ordinary shares through its affiliated entity, Opaleye, L.P., across three transactions in December 2025.

Stakeholder Impact

• Shareholders: The insider buying could be interpreted as a positive signal, potentially increasing investor confidence and demand for the stock.
• Management: The increased stake by a director aligns their interests more closely with other shareholders.

Key Dates

Recommendation

While the insider buying by Opaleye Management Inc. is a positive signal, indicating confidence from a significant shareholder and director, this Form 4 filing alone does not provide sufficient fundamental information (e.g., financial performance, strategic updates, pipeline progress) to warrant a 'buy' recommendation. It suggests a favorable internal view, but investors should 'hold' and await further comprehensive financial disclosures or operational updates from Sol-Gel Technologies Ltd. before making a more aggressive investment decision. The purchases are relatively small in the context of the total beneficial ownership, and the disclaimer of beneficial ownership (except for pecuniary interest) is standard but noteworthy.

Keywords

Sol-Gel Technologies, SLGL, Opaleye Management, Insider Buying, Share Purchase, Beneficial Ownership, SEC Form 4, Director Purchase, 10% Owner